Thursday, December 14Breaking News Today. #therealthing

Tag: Erdheim-Chester Disease

FDA approves Vemurafenib for patients with Erdheim-Chester Disease

FDA approves Vemurafenib for patients with Erdheim-Chester Disease

Health 
The U.S. Nourishment and Drug Administration today expanded the endorsement of Zelboraf (vemurafenib) to incorporate the treatment of certain grown-up patients with Erdheim-Chester Disease (ECD), an uncommon malignancy of the blood. Zelboraf is shown to treat patients whose disease cells have a particular hereditary change known as BRAF V600. This is the main FDA-affirmed treatment for ECD. ...